CLT 85 [SKI 294/CLT 85]
CLT 85 [SKI 294/CLT 85]
规格:
货期:
编号:TS212347
品牌:Testobio
| 产品名称： | CLT 85 SKI 294/CLT 85 |
|---|---|
| 商品货号： | TS212347 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Cancer,Adenocarcinoma,Cancer |
| Applications： | The antibody reacts with human colon adenocarcinoma cells (11 of 17 cell lines tested). This is one of a panel of hybridomas (ATCC HB-8232 and TS212347 through ATCC HB-8252) that can be used to diagnose and classify human gastrointestinal tract cancers. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human colon adenocarcinoma |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human colon adenocarcinoma |
| Comments： | Animals were immunized with a human colon cancer cell line (Tallevi). The antibody reacts with human colon adenocarcinoma cells (11 of 17 cell lines tested). It does not react with frozen sections of normal adult tissues. This is one of a panel of hybridomas (ATCC HB-8232 and TS212347 through ATCC HB-8252) that can be used to diagnose and classify human gastrointestinal tract cancers. |
| Complete Growth Medium： | RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.1 mM hypoxanthine and 0.016 mM thymidine, 90%; fetal bovine serum, 10%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1 |
| Name of Depositor： | Sloan-Kettering Institute for Cancer Research |
| U.S. Patent Number： | |
| References： | Cordon-Cardo C, et al. Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies. US Patent 4,579,827 dated Apr 1 1986 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
CLT 85 [SKI 294/CLT 85]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | CLT 85 SKI 294/CLT 85 |
|---|---|
| 商品货号： | TS212347 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Cancer,Adenocarcinoma,Cancer |
| Applications： | The antibody reacts with human colon adenocarcinoma cells (11 of 17 cell lines tested). This is one of a panel of hybridomas (ATCC HB-8232 and TS212347 through ATCC HB-8252) that can be used to diagnose and classify human gastrointestinal tract cancers. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human colon adenocarcinoma |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human colon adenocarcinoma |
| Comments： | Animals were immunized with a human colon cancer cell line (Tallevi). The antibody reacts with human colon adenocarcinoma cells (11 of 17 cell lines tested). It does not react with frozen sections of normal adult tissues. This is one of a panel of hybridomas (ATCC HB-8232 and TS212347 through ATCC HB-8252) that can be used to diagnose and classify human gastrointestinal tract cancers. |
| Complete Growth Medium： | RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.1 mM hypoxanthine and 0.016 mM thymidine, 90%; fetal bovine serum, 10%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1 |
| Name of Depositor： | Sloan-Kettering Institute for Cancer Research |
| U.S. Patent Number： | |
| References： | Cordon-Cardo C, et al. Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies. US Patent 4,579,827 dated Apr 1 1986 |
